ILUBE Eye drops, solution Ref.[2455] Active ingredients: Acetylcysteine

ILUBE Eye Drops contain benzalkonium chloride which may cause eye irritation or discolour soft contact lenses. Avoid contact with soft contact lenses. Patients should be instructed to remove contact lenses prior to application and wait at least 15 minutes before reinsertion. Benzalkonium chloride has been reported to cause eye irritation, symptoms of dry eyes and may affect the tear film and corneal surface. Should be used with caution in dry eye patients and in patients where the cornea may be compromised. Patients should be monitored in case of prolonged use.

No interaction studies have been performed.

Medical advice must be sought before taking ILUBE Eye Drops with any medication, including medicines obtained without a prescription.

This product should not be taken if the patient is pregnant, might get pregnant, or is breast-feeding without seeking medical advice.

Patients must be advised that their vision may be blurred after using Ilube Eye Drops and must not drive or use any machines, unless their vision is clear.

Patient may experience itching, redness and/or irritation in their eye(s).

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

Not applicable.